“When my cardiologist indicated it was time for me to surgically address my ascending aortic aneurysm and degrading aortic valve, I undertook some research into what would be my best choice. I did not want to face the prospect of another open heart procedure when in my 80s, as would probably be required if I […]
ISPOR Meeting Presentation
May 21, 2013 By
Economic Model of the Life-time Cost Impact of Heart Valve Prosthetic Choice Life-time costs savings of choosing an On-X® Prosthetic Heart Valve with no risk of re-operation compared to a stented tissue valve replaced with a transcatheter valve is estimated at $376,000 AUSTIN, TX — May 21, 2013 — On-X® Life Technologies, Inc. (On-X LTI) […]
On-X Life Technologies Submits for FDA/CE Approval
October 22, 2012 By
Reduced Anticoagulation Indication for On-X Aortic Heart Valve If approval is received, the On-X valve will become the first aortic valve that allows patients to be maintained at levels of anticoagulation below currently recommended professional society guidelines, helping to lessen anticoagulation – related complications AUSTIN, TX – October 22, 2012 – On-X® Life Technologies, Inc. […]
Clinical Update Thirty-Three: On-X Pure Carbon Valve
December 10, 2010 By
Does the On-X Pure Carbon Valve behave like a mechanical or tissue valve? Results of an intermediate term study of 737 Canadian patients show decreased risk with the On-X® Prosthetic Heart Valve.1 A study published in the November 2010 issue of The Journal of Thoracic and Cardiovascular Surgery found approximately 30% improvement in aortic […]
